C12Y 117/03
Oxidoreductases acting on ch or ch2 groups: with oxygen as acceptor
Official title: with oxygen as acceptor (1.17.3)
C12Y117/03 (Oxidoreductases acting on ch or ch2 groups: with oxygen as acceptor) appears on 12 US grants and 17 published applications in this corpus.
Search patents in C12Y- Granted patents
- 12
- Published applications
- 17
- Assignees
- 16
- Inventors
- 52
- Latest grant
- 5 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 2 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 3 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures5 Mar 2024US 11,920,153 B2Alma Mater Studiorum - Università di Bologna
- Methods and devices to detect the presence of a condition associated with ATP depletion in a subject12 Jan 2021US 10,889,846 B2Sarissa Biomedical Limited
- Methods of diagnosis and treatment involving nitrite9 Jun 2020US 10,675,253 B2Board of Supervisors of Louisiana State University
- Processes for the formation of furandicarboxylic acid (FDCA) via a multistep biocatalytic oxidation reaction of 5-hydroxymethylfurfural (HMF)9 Jul 2019US 10,344,307 B2Biome Bioplastics Limited
- Strain of Lactobacillus rhamnosus and its metabolites for use in inhibiting xanthine oxidase and treating gout2 May 2017US 9,636,368 B2Food Industry Research and Development Institute
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures6 Aug 2026US 2026/0226408 A1Alma Mater Studiorum - Università di Bologna
- Methods and systems for applications involving antigen-presenting cells26 Jun 2025US 2025/0205355 A1Viska Bio, Inc.
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures1 Aug 2024US 2024/0254436 A1Alma Mater Studiorum - Università di Bologna
- Products and methods for the treatment of nicotine dependence6 Jul 2023US 2023/0212533 A1The Board of Trustees of Western Michigan University
- G-to-t base editors and uses thereof8 Sep 2022US 2022/0282275 A1President and Fellows of Harvard College
Most cited
By later US patents
- Treatment of lesions33US 6,682,732 B1University of Bath · 2004
- Deodorized water-in-oil emulsion containing fish oil13US 4,961,939 ANabisco Brands, Inc. · 1990
- Method and test composition for the determination of the substrate for xanthine oxidase7US 4,341,868 AKyowa Hakko Kogyo Co., Ltd. · 1982
- Antitumor agents3US 6,716,426 B12004
- Preparation of high purity xanthine oxidase from bovine milk1US 4,172,763 AUniversity of Delaware · 1979